Apoptosis Regulator BAX Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)
Apoptosis regulator BAX market is anticipated to grow at a significant CAGR during the forecast period. Apoptosis regulator BAX is also known as BCL-2-like protein 4. It is a protein that is encoded by the BAX gene in humans. Additionally, BAX is a member of the Bcl-2 gene family which form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. The major factor driving the market growth is the increasing prevalence of liver cancer across the globe.
According to the American Cancer
Society, in 2022, liver cancer is a leading cause of mortality each year
globally. Additionally, an estimated 41,260 new cases will be diagnosed with
liver cancer in the US. Out of which 28,600 cases will be diagnosed in men and
12,660 will be diagnosed in women. Furthermore, more than 800,000 people are
diagnosed with liver cancer each year across the globe. Moreover, BAX is a
central cell death regulator and a core regulator of the intrinsic pathway of apoptosis.
Additionally, it controls apoptosis in normal and cancer cells. Hence, the
increasing prevalence of liver cancer is driving the demand for apoptosis
regulator BAX.
Some major players in the market include Genervon
Biopharmaceuticals LLC, Lytix Biopharma AS, among others. The market players
are contributing significantly to the growth of the market by the adoption of
various strategies including mergers & acquisitions, geographical
expansion, partnerships and collaborations, and new product launches, to stay
competitive in the market. For instance, in July 2021, Ipsen has signed an
exclusive global collaboration agreement with BAKX Therapeutics Inc. The
collaboration was aimed to research, develop, manufacture and commercialize
BKX-001 as a potential treatment for leukemia, lymphoma and solid tumors.
To Request a Sample of our Report on Apoptosis Regulator
BAX Market: https://www.omrglobal.com/request-sample/apoptosis-regulator-bax-market
Market Coverage
•
The market number available for – 2022-2030
•
Base year- 2022
•
Forecast period- 2023-2030
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- Genervon Biopharmaceuticals
LLC, and Lytix Biopharma AS, among others.
Apoptosis Regulator BAX Market Report by Segment
By Type
• GM-6
• HU-010
• LTX-401
• Others
By Application
• Liver
Cancer
• Melanoma
• Stroke
• Parkinson’s
Disease
• Others
A
full Report of Apoptosis Regulator BAX Market is Available @ https://www.omrglobal.com/industry-reports/apoptosis-regulator-bax-market
Apoptosis Regulator BAX Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market
Research (OMR) is a market research and consulting company known for its crisp
and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services. The
company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services
through another subsidiary Encanto Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment